Redmile as of March 31, 2017
Portfolio Holdings for Redmile
Redmile holds 60 positions in its portfolio as reported in the March 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Array BioPharma | 7.4 | $114M | 13M | 8.94 | |
| Penumbra (PEN) | 5.6 | $86M | 1.0M | 83.45 | |
| Amicus Therapeutics (FOLD) | 5.3 | $81M | 11M | 7.13 | |
| Puma Biotechnology (PBYI) | 4.2 | $64M | 1.7M | 37.20 | |
| Clovis Oncology | 4.0 | $62M | 973k | 63.67 | |
| Atara Biotherapeutics (ATRA) | 3.6 | $56M | 2.7M | 20.55 | |
| Agios Pharmaceuticals (AGIO) | 3.4 | $53M | 903k | 58.40 | |
| Molina Healthcare (MOH) | 3.4 | $52M | 1.1M | 45.60 | |
| Prothena (PRTA) | 3.1 | $47M | 850k | 55.79 | |
| Seattle Genetics | 2.8 | $44M | 696k | 62.86 | |
| Incyte Corporation (INCY) | 2.7 | $41M | 308k | 133.67 | |
| Gw Pharmaceuticals Plc ads | 2.6 | $40M | 333k | 120.94 | |
| Alder Biopharmaceuticals | 2.6 | $40M | 1.9M | 20.80 | |
| Xencor (XNCR) | 2.5 | $38M | 1.6M | 23.92 | |
| Wave Life Sciences (WVE) | 2.3 | $35M | 1.3M | 27.50 | |
| Global Blood Therapeutics In | 2.2 | $34M | 934k | 36.85 | |
| Oxford Immunotec Global | 2.0 | $31M | 2.0M | 15.49 | |
| Boston Scientific Corporation (BSX) | 1.9 | $30M | 1.2M | 24.87 | |
| Inc Resh Hldgs Inc cl a | 1.9 | $29M | 634k | 45.85 | |
| Anthem (ELV) | 1.9 | $29M | 175k | 165.38 | |
| Chimerix (CMRX) | 1.8 | $28M | 4.3M | 6.38 | |
| Neurocrine Biosciences (NBIX) | 1.8 | $27M | 622k | 43.30 | |
| ICU Medical, Incorporated (ICUI) | 1.6 | $25M | 161k | 152.70 | |
| Neuroderm Ltd F | 1.6 | $25M | 924k | 26.55 | |
| Regenxbio Inc equity us cm (RGNX) | 1.6 | $25M | 1.3M | 19.30 | |
| Jounce Therapeutics | 1.5 | $23M | 1.1M | 20.22 | |
| Immunomedics | 1.4 | $22M | 3.4M | 6.47 | |
| Patheon N V | 1.4 | $22M | 827k | 26.34 | |
| Diplomat Pharmacy | 1.3 | $20M | 1.3M | 15.95 | |
| Endologix | 1.3 | $20M | 2.7M | 7.24 | |
| Express Scripts Holding | 1.3 | $19M | 294k | 65.91 | |
| Nanostring Technologies (NSTGQ) | 1.2 | $19M | 934k | 19.87 | |
| La Jolla Pharmaceuticl Com Par | 1.2 | $18M | 605k | 29.85 | |
| Catalent (CTLT) | 1.1 | $18M | 624k | 28.32 | |
| Cascadian Therapeutics | 1.1 | $17M | 4.1M | 4.14 | |
| PAREXEL International Corporation | 1.1 | $16M | 260k | 63.11 | |
| Spectranetics Corporation | 1.1 | $16M | 557k | 29.12 | |
| Blueprint Medicines (BPMC) | 1.0 | $16M | 400k | 39.99 | |
| ImmunoGen | 1.0 | $15M | 4.0M | 3.87 | |
| Syros Pharmaceuticals | 1.0 | $15M | 953k | 15.93 | |
| eHealth (EHTH) | 0.9 | $14M | 1.2M | 12.04 | |
| Audentes Therapeutics | 0.9 | $14M | 821k | 17.04 | |
| Array Biopharma Inc note 3.000% 6/0 | 0.8 | $13M | 9.0M | 1.42 | |
| Cytomx Therapeutics (CTMX) | 0.8 | $12M | 682k | 17.27 | |
| McKesson Corporation (MCK) | 0.8 | $12M | 78k | 148.26 | |
| Charles River Laboratories (CRL) | 0.7 | $11M | 121k | 89.95 | |
| Invitae (NVTAQ) | 0.6 | $9.0M | 812k | 11.06 | |
| Model N (MODN) | 0.6 | $8.6M | 822k | 10.45 | |
| Proqr Thrapeutics N V shs euro (PRQR) | 0.5 | $7.8M | 1.6M | 5.00 | |
| Fate Therapeutics (FATE) | 0.4 | $6.5M | 1.4M | 4.55 | |
| Dynavax Technologies (DVAX) | 0.4 | $6.1M | 1.0M | 5.95 | |
| Surgery Partners (SGRY) | 0.4 | $5.9M | 304k | 19.50 | |
| Avexis | 0.2 | $3.4M | 45k | 76.03 | |
| Aclaris Therapeutics (ACRS) | 0.2 | $2.7M | 91k | 29.82 | |
| Ra Pharmaceuticals | 0.1 | $2.4M | 111k | 21.29 | |
| Aurinia Pharmaceuticals (AUPH) | 0.1 | $1.0M | 140k | 7.34 | |
| UnitedHealth (UNH) | 0.0 | $298k | 1.8k | 163.74 | |
| Amedisys (AMED) | 0.0 | $247k | 4.8k | 51.18 | |
| Castlight Health | 0.0 | $37k | 10k | 3.62 | |
| Adverum Biotechnologies | 0.0 | $60k | 22k | 2.70 |
